Documents Savoirs Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival Ducreux Michel, Oberic Lucie, Viret Frédéric, Baey Charlotte, Ychou Marc, Bennouna Jaafar, Adenis Antoine, Peiffert Didier, Mornex Françoise, Pignon Jean-Pierre, Celier Patrice, Berille Jocelyne
